Key result
De-novo ECG changes post-COVID-19 in athletes linked to ~88% rate of cardiac sequelae on CMR.
Why the study?
The efficacy of comparing pre-COVID-19 and post-COVID-19 12-lead ECGs to identify myopericarditis in athletes had not been reported, and the prevalence and significance of de-novo ECG changes following COVID-19 infection were unclear.
Does comparing pre- and post-COVID-19 12-lead ECGs to detect de-novo ECG changes identify inflammatory cardiac sequelae on CMR in elite soccer players?
Cohort (n=511)
Yes
Does comparing pre- and post-COVID-19 12-lead ECGs to detect de-novo ECG changes identify inflammatory cardiac sequelae on CMR in elite soccer players?
Comparing post-COVID-19 12-lead ECGs with pre-infection baseline ECGs is a pragmatic and effective screening tool in elite athletes, as 88% of those with de-novo ECG changes had cardiac inflammation on CMR, including 20% who had no cardiac symptoms.
Answers are grounded in this paper and cite their sources.
De-novo ECG changes may identify post-COVID cardiac inflammation in elite athletes; hypothesis-generating for routine pre-post ECG screening.
BACKGROUND AND AIM: The efficacy of pre-COVID-19 and post-COVID-19 infection 12-lead ECGs for identifying athletes with myopericarditis has never been reported. We aimed to assess the prevalence and significance of de-novo ECG changes following COVID-19 infection. METHODS: In this multicentre observational study, between March 2020 and May 2022, we evaluated consecutive athletes with COVID-19 infection. Athletes exhibiting de-novo ECG changes underwent cardiovascular magnetic resonance (CMR) scans. One club mandated CMR scans for all players (n=30) following COVID-19 infection, despite the absence of cardiac symptoms or de-novo ECG changes. RESULTS: 511 soccer players (median age 21 years, IQR 18-26 years) were included. 17 (3%) athletes demonstrated de-novo ECG changes, which included reduction in T-wave amplitude in the inferior and lateral leads (n=5), inferior leads (n=4) and lateral leads (n=4); inferior T-wave inversion (n=7); and ST-segment depression (n=2). 15 (88%) athletes with de-novo ECG changes revealed evidence of inflammatory cardiac sequelae. All 30 athletes who underwent a mandatory CMR scan had normal findings. Athletes revealing de-novo ECG changes had a higher prevalence of cardiac symptoms (71% vs 12%, p<0.0001) and longer median symptom duration (5 days, IQR 3-10) compared with athletes without de-novo ECG changes (2 days, IQR 1-3, p<0.001). Among athletes without cardiac symptoms, the additional yield of de-novo ECG changes to detect cardiac inflammation was 20%. CONCLUSIONS: 3% of athletes demonstrated de-novo ECG changes post COVID-19 infection, of which 88% were diagnosed with cardiac inflammation. Most affected athletes exhibited cardiac symptoms; however, de-novo ECG changes contributed to a diagnosis of cardiac inflammation in 20% of athletes without cardiac symptoms.
No takes yet. Share an insight, caveat, or question.
Bhatia et al. (2023) conducted a cohort in COVID-19 infection in elite soccer players (n=511). De-novo 12-lead ECG changes following COVID-19 infection vs. Normal post-COVID-19 12-lead ECG (including n=30 undergoing mandatory CMR) was evaluated on Inflammatory cardiac sequelae (acute pericarditis or definite/probable/possible/healed myocarditis) on downstream TTE and CMR imaging. De-novo 12-lead ECG changes occurred in 3% (17/511) of elite soccer players post-COVID-19, with 88% (15/17) of those showing inflammatory cardiac sequelae on CMR.
Synapse has enriched 10 related papers. Consider them for comparative context: